Delivery Order SPE2DB20D3303-SPE2DB24FA1LJ

Award Date 7/25/24
Potential Completion Date 7/26/24
Potential Value $2.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $3,956.17 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 MG TABLET, a pharmaceutical product. This order falls under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which enables the agency to efficiently procure a comprehensive range of medical commodities to support military treatment programs and facilities...
The U.S. Defense Logistics Agency (DLA) awarded a $4,470.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DESCOVY 200-25 MG TABLET UU 30S. This delivery order was placed under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,244.30, is for the supply of DESCOVY 200-25 MG TABLET 30S, a prescription medication. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which enables DLA to efficiently procure a comprehensive range of medical...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DESCOVY 200-25 MG TABLET. The contract has a firm fixed price of $12,948.90 and a period of performance ending on July 31, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for...
The U.S. Defense Logistics Agency (DLA) awarded a $19,407.76 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide DESCOVY 200-25 MG TABLET UU 30S pharmaceutical products. This delivery order falls under a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA, which serves as the primary vehicle for the company to deliver pharmaceuticals and medical...
This is a $10,235.48 firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for DESCOVY 200-25 MG TABLET, a prescription medication, with a period of performance through February 16, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a...
This is a $5,608.29 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of DESCOVY 200-25 MG TABLET, a prescription medication, with a performance period through December 12, 2023. This order is placed under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
The U.S. Defense Logistics Agency (DLA) awarded a $1,782.27 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide DESCOVY 200-25 MG TABLET medication. This contract supports federal healthcare programs, particularly for military personnel and veterans, with a range of pharmaceutical products and medical supplies. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a leading global pharmaceutical sourcing and distribution services company, to provide DESCOVY 200-25MG 30S pharmaceuticals. The contract has a ceiling value of $35,925.70 and an ultimate completion date of August 10, 2022. This award is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 through December 31, 2025, which...
This is a delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for 4,564,804,933 units of DESCOVY 200-25 MG TABLET. The $12,030.92 firm-fixed-price contract has a period of performance through June 5, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB24FA1LJ
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $2,937.60 delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide DESCOVY 200-25 MG TABLET medication. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which allows DLA Troop Support Medical to efficiently procure a comprehensive range of medical commodities, including pharmaceuticals, to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and is expected to be completed by July 26, 2024.

Generated 10/27/24, 4:11 AM